Position in DNLI
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,028
+$260 QoQ
Shares Held
40
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#265
of 290 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avion Wealth holds $288,734 across 82 Biotechnology names. DNLI ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
53 | $26,326 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
500 | $17,695 | |
| 3 | EXEL |
Exelixis, Inc.
|
260 | $14,146 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
352 | $13,713 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
153 | $12,471 | |
| 6 | MRNA |
Moderna, Inc.
|
171 | $11,975 | |
| 7 | INCY |
Incyte Corp
|
105 | $11,902 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
55 | $10,300 |
All Filings in DNLI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,028 | 40 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $768 | 40 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $660 | 40 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $580 | 40 | Shares | Sole | 2025-10-24 | |
| 2025-03-31 | $339 | 25 | Shares | Sole | 2025-05-09 | |
| 2024-09-30 | $728 | 25 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $580 | 25 | Shares | Sole | 2024-07-26 | |
| No filing history on record for this holder in this stock. | ||||||